top of page
Master of Microbial Biotechnology Candidate
Industry Experience
Explore my portfolio.
-
Led a team of six student consultants to determine attractiveness of the sustainable aviation fuel (SAF) market.
-
Performed market analysis and regulatory landscape assessment on the SAF market in North America and Europe to create the most effective go-to-market strategy for Novozymes’ Biological Solutions platform.
-
Conducted a voice-of-customer (VoC) campaign to gain key insights into the SAF market from industry leaders
-
Led a team of six student consultants to determine the market potential of a novel platelet-derived peptide therapeutic for pluri-microbial pneumonia.
-
Performed a market assessment for platelet-rich plasma therapeutics and antimicrobial peptide drugs.
-
Explored the regulatory landscape and novel delivery methods for respiratory biologic drugs.
-
Worked in a team of four graduate student consultants to determine how and where Baebies can enter the NICU diagnostics market with their point-of-care device Finder.
-
Conducted market research and a Voice-of-Customer (VoC) campaign to assess the current NICU diagnostics market and identify key unmet needs in the screening of neonatal conditions and diseases.
-
Evaluated competitive landscape to identify existing diagnostic platforms and limitations in terms of performance and menu expansion.
-
Worked in a team of five graduate student consultants to strategize whether FujiFilm should enter the Chinese CDMO market.
-
Performed market research and regulatory landscape assessment on the Chinese biologics market to formulate the most effective Go-To-Market strategy.
-
Conducted a Voice-of-Customer (VoC) campaign to investigate competitive landscape and customer perception of a foreign CDMO in the Chinese market.
-
Scouted upcoming technology trends utilized across Chinese biomanufacturing.
-
Worked in at team of five student consultants to assess a provisional patent and identify key success factors for product commercialization.
-
Refined the business plan of a soon-to-be start-up-company with RNA-aptamer anti-coagulation technology by conducting an extensive market analysis.
-
Examined patent landscape to perform a Freedom-to-Operate (FTO) analysis on novel anticoagulant technology.
-
Identified three key markets to pursue for maximum profitability with the least competition through out-of-the-box thinking and critical analysis.
bottom of page